Transition From Donor Milk: a Feasibility Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28+
SponsorAugusta University
About this trial
Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.
Eligibility criteria
Qualifiers
Greater than 1,250 grams
At least 28 days of life
Diet consisting of donor human milk with/without mother's own milk
Disqualifiers
Birth weight below the 5th percentile
History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder
Congenital anomalies
Care team discretion
Trial design
Treatments tested in this trial
- Preterm Infant Formula
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
1Wellstar-MCG30912, AugustaGeorgia, United States
Sponsors and collaborators
Augusta University
Lead sponsor
Source ClinicalTrials.gov